EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Survival Outcomes Associated With Prolonged Pembrolizumab After Definitive Chemoradiation for Non–small Cell Lung Cancer

A Homeniuk, A Syed, A Atrash

Clinical Oncology · 2026-09 · 57 · 104227

DOI: 10.1016/j.clon.2026.104227 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Oncology, 2026-09. Verfasst von A Homeniuk und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, University of Pittsburgh Medical Center, 111 S. Front St., Harrisburg, PA 17101, USA. Electronic address: homeniuka@…. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Humanized, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Antineoplastic Agents, Immunological. Die Arbeit nennt 11 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, Monoclonal, HumanizedCarcinoma, Non-Small-Cell LungLung NeoplasmsAntineoplastic Agents, ImmunologicalChemoradiotherapyHumansFemaleMaleRetrospective StudiesAgedMiddle Aged

Stichwörter der Autor:innen

NSCLCnon-small cell lung cancerpembrolizumabreal word studysurvival

Substanzen

Antibodies, Monoclonal, HumanizedpembrolizumabAntineoplastic Agents, Immunological

Autor:innen und Institutionen

  • Department of Internal Medicine, University of Pittsburgh Medical Center, 111 S. Front St., Harrisburg, PA 17101, USA. Electronic address: homeniuka@upmc.edu.
  • Drexel University College of Medicine, 60 N. 36th Street Philadelphia, PA 19104, USA. Electronic address: azs32@drexel.edu.
  • Department of Internal Medicine, University of Pittsburgh Medical Center, 111 S. Front St., Harrisburg, PA 17101, USA. Electronic address: atrasha@upmc.edu.

Zitieren

APA

Homeniuk, A., Syed, A., & Atrash, A. (2026). Survival Outcomes Associated With Prolonged Pembrolizumab After Definitive Chemoradiation for Non–small Cell Lung Cancer. Clinical Oncology, 57, 104227. https://doi.org/10.1016/j.clon.2026.104227

Vancouver

Homeniuk A, Syed A, Atrash A. Survival Outcomes Associated With Prolonged Pembrolizumab After Definitive Chemoradiation for Non–small Cell Lung Cancer. Clinical Oncology. 2026;57:104227. doi:10.1016/j.clon.2026.104227

BibTeX
@article{Homeniuk2026,
  author = {Homeniuk, A and Syed, A and Atrash, A},
  title = {Survival Outcomes Associated With Prolonged Pembrolizumab After Definitive Chemoradiation for Non–small Cell Lung Cancer},
  journal = {Clinical Oncology},
  year = {2026},
  volume = {57},
  pages = {104227},
  doi = {10.1016/j.clon.2026.104227}
}
Kostenlos starten →